Nuova Ompi – Stevanato Group receives Frost & Sullivan award

Nuova Ompi – Stevanato Group has been honoured with the Europe Product Differentiation Excellence Award for Prefillable Syringes for its differentiation approach into the prefilled syringe market, by …

Nuova Ompi – Stevanato Group has been honoured with the Europe Product Differentiation Excellence Award for Prefillable Syringes for its differentiation approach into the prefilled syringe market, by Frost & Sullivan, a global research organization which monitors more than 300 industries and 250,000 companies with more than 1,800 analysts. According to Frost & Sullivan“s Report, With the exception of Nuova Ompi, none of the other PFS suppliers possess the capacity to design and manufacture syringe assembly machinery. The group“s Optrel unit manufactures inspection machines for containers. This capacity enables Nuova Ompi to meet the specific dimensional requirements of its customers. In a highly competitive and dynamic environment, such as the prefilled syringe market, our group opted to invest in customer service innovation, said Nuova Ompi-Stevanato Group president Sergio Stevanato. Our strategy is to manufacture and supply customized PFS syringes that are competitively priced and of high quality. In addition, we recognize that meeting the specific demands for the vaccine and the needs of our biotech customers would be a major growth driver for Ompi. This is made possible thanks to our unique specifications, whereby the manufacturing lines at Ompi are flexible and cater even to small volume requests from customers. This Award offers further proof of our superior production capabilities and demonstrates that we are on the right path towards the commercial production of high quality pharmaceutical systems, Stevanato said. We are grateful for the acknowledgement and the impact it will have on our future growth, especially in meeting specific requests for the vaccine and from our biotech customers. Nowadays the Stevanato Group is offering a complete range of pharmaceutical containers made from glass tubing, and the recent extension of our EZ-fillTM sterile production from syringes to other pharmaceutical containers like vials & cartridges is just one step towards the development of innovative packaging systems. For the Award, the following criteria were used to benchmark the performance of the Nuova Ompi -Stevanato Group against key competitors: o Unique Features/Functionality; o Quality/Complexity; o Customization; o Matched to Target Markets Needs; o Brand Perception/Uniqueness of the Product. The company is receiving this accolade for its unique ability to differentiate itself from the other players in the market, especially the large syringe suppliers. A successful product differentiation strategy based on the successful cooperation of the groups“ glass and engineering divisions is considered a key-driver in the field of syringe assembly machinery, and has helped to develop proprietary solutions for production. This close collaboration between the Engineering division (Spami, Optrel) and the Glass division (Nuova Ompi) on the development of new machines and new devices is the main strength of the group. Nuova Ompi President Sergio Stevanato received the Award at a special Frost & Sullivan banquet on 7 October at the Sofitel in Bruxelles.